Day: January 21, 2025

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp”), a leading mining development company focused on critical metals and minerals and producing strategic products essential to electrification and next generation technologies for Europe and its western world partners through its Tanbreez Greenland Rare Earth Mine and Wolfsberg Lithium Project, today announced its Board of Directors has approved a comprehensive bitcoin (“BTC”) treasury strategy, adopting BTC as a primary asset in its treasury program. As part of the convertible note financing, led by JBA Asset Management, Critical Metals Corp may have access up to $500 million to purchase BTC subject to the conditions of the Transaction Documents, with $100 million closing in the first tranche, which may be used to purchase BTC,...

Vancouver, Canada, Jan. 21, 2025 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI), a technology-driven company committed to sustainable innovation, today announced the appointment of Barrett Mooney, Ph.D., as its Chief Operating Officer. Dr. Mooney’s extensive expertise in agriculture technology, sustainability, and strategic business growth positions him as a pivotal figure in AgriFORCE’s mission to integrate cutting-edge solutions into its newly acquired cryptocurrency mining and agricultural facility in Alberta, Canada. Dr. Barrett Mooney: Pioneering Technological Advancements in Agriculture and Sustainability Dr. Mooney holds a Ph.D. in Agricultural and Biological Engineering from the University of Florida and brings a wealth of experience in leveraging technology to drive sustainable practices. He co-founded...

Bowie, Maryland, Jan. 21, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (“Blink” or the “Company”) (Nasdaq: BLNK), a leading owner, operator, provider, and manufacturer of electric vehicle (“EV”) charging equipment and services, today announced that it received written notice from the Securities and Exchange Commission (“SEC”) that the SEC has concluded the previously disclosed investigation of the Company, and the SEC does not intend to recommend an enforcement action against the Company. “We are pleased to move forward from this longstanding legacy issue, which started in July 2023,” said Aviv Hillo, Blink’s General Counsel and Executive Vice President of Mergers & Acquisitions. “Concluding this SEC matter not only provides closure but also eliminates a source of legal expense, contributing to a further reduction in our operating...

CALGARY, Alberta, Jan. 21, 2025 (GLOBE NEWSWIRE) — Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera“, “PEI” or the “Corporation“) This report continues Prospera’s monthly production updates, ensuring stakeholders receive consistent and timely insights into operational performance and key field developments. All production numbers referenced are sales numbers of the Company at its current working interest, pre-royalties. However, the company continues to receive revenue for JV partners in default in both its Cuthbert and Brooks properties. Additionally, a significant portion of the company’s natural gas production is consumed within the field for fuel gas and is thus not included in sales numbers. In December, field production was estimated to be 661 boe/d (91% oil). From January 1st to January 19th,...

SINGAPORE, Jan. 21, 2025 (GLOBE NEWSWIRE) — Davis Commodities Limited (NASDAQ: DTCK), a global leader in commodities and logistics, and Kohai, an innovative gaming and eSports organization, today announced the signing of a Memorandum of Understanding (MOU) to jointly invest in Kinetic AI, a company that develops enterprise solutions using artificial intelligence (AI). Empowering Businesses with Innovative AI Solutions The global AI market is forecasted to surpass $1 trillion by 2030, showcasing the immense growth potential within the artificial intelligence sector. At the forefront of this transformative industry is Kinetic AI, a pioneering company specializing in crafting cutting-edge artificial intelligence solutions. Leveraging Tencent’s open-source AI language model and a range of advanced AI technologies, Kinetic AI...

ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on advancing first-in class, non-opioid, Nav 1.7 inhibitor treatments for chronic and acute pain, announced today that dosing of the first patient in its Phase 2b clinical trial, referred to as HALT-CINP (Halneuron® Treatment of Chemotherapy Induced Neuropathic Pain), evaluating Halneuron® to treat neuropathic pain associated with prior chemotherapy treatment (“CINP”) is expected to occur in the first quarter of 2025. Halneuron® is a first-in-class, Nav 1.7 specific voltage gated sodium channel inhibitor being developed as an alternative to pain treatment with opioids. Halneuron® treated patients demonstrated a statistically significant reduction in cancer-related pain in a previous...

Cyber GRC solution Xacta is now included in the StateRAMP product list at the High impact level, reinforcing Telos’ commitment to cybersecurity for state and local government. ASHBURN, Va., Jan. 21, 2025 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it has successfully achieved State Risk and Authorization Management Program (StateRAMP) High authorization, signifying its commitment to robust cybersecurity practices and compliance with the StateRAMP security standards for state and local government agencies. The software-as-a-service (SaaS) version of Telos’ premiere cyber governance, risk and compliance (GRC) platform, Xacta®, has undergone a thorough evaluation and passed...

BEIJING, Jan. 21, 2025 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced that the Company’s CEO, Haogang Yang, has been honored with the prestigious “Best CEO” award at the 9th Zhitong Finance Capital Market Annual Conference and Listed Company Awards Ceremony, held in Shenzhen, China, on December 11, 2024. The Zhitong Finance Capital Market Annual Conference, first launched in 2016, has evolved into a premier platform for recognizing outstanding performance among listed companies in the Hong Kong and US stock markets. Its influence and credibility have earned widespread acclaim from global investors,...

Tuesday, 4 February 2025 at 10.00 – 11.00am CETIn connection with the publication of Coloplast’s interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event. Coloplast will be represented by: Kristian Villumsen – President & CEOAnders Lonning-Skovgaard – Executive Vice President, CFOAleksandra Dimovska – Vice President, Investor RelationsSimone Dyrby Helvind – Senior Manager, Investor Relations WebcastFor participants who do not wish to actively participate in the Q&A...

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelis®) with the potential to improve trabectedin’s therapeutic window in soft-tissue sarcoma patients Combined mechanisms have the potential to enhance progression-free survival (PFS) in some of the largest cohorts of patients with soft-tissue sarcoma Topline safety data of the combination of SON-1010 with trabectedin is expected in H2 calendar year 2025 Sonnet management discusses what this expansion means in a Virtual Investor “What This Means” segment; Access here PRINCETON, NJ, Jan. 21, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing...